(Q53092137)

11 May 2018

title

Treatment effect of adalimumab and infliximab in Japanese psoriasis patients: results in a single community-based hospital. (English)

1 reference

11 May 2018

0 references

Shinji Noda

1

1 reference

11 May 2018

Kyoko Mizuno

series ordinal

2

1 reference

11 May 2018

Makoto Adachi

series ordinal

3

1 reference

11 May 2018

publication date

29 November 2011

1 reference

11 May 2018

The Journal of Dermatology

published in

1 reference

11 May 2018

volume

39

1 reference

11 May 2018

issue

3

1 reference

11 May 2018

page(s)

265-268

1 reference

11 May 2018

Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01312.X

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01312.X

Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01312.X

Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01312.X

Calcipotriol solution for the treatment of scalp psoriasis: evaluation of efficacy, safety and acceptance in 3,396 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01312.X

Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01312.X

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01312.X

Efficacy of systemic treatments for moderate to severe plaque psoriasis: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01312.X

10.1111/J.1346-8138.2011.01312.X

21 January 2018

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018